Evidence map›Paper›PMID 34805873›Full record

ArticleJournal of interventional medicine2019

Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for hepatocellular carcinoma with macrovascular invasion or extrahepatic metastases.

Mengfei Wu, Shanshan Gao, Huadan Song, Zihan Zhang, Zhiyuan Zheng, Zhiping Yan, Xiaolin Wang, Jianhua Wang, Lingxiao Liu

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of interventional medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Mengfei WuDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Shanshan GaoDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Huadan SongDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zihan ZhangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zhiyuan ZhengDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zhiping YanDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Xiaolin WangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Jianhua WangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Lingxiao LiuDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the safety and efficacy of percutaneous microwave ablation (MWA) combined with simultaneous transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI) or extrahepatic metastases (EHM).

methodsBetween August 2012 and April 2017, 101 patients with MVI/EHM of HCC underwent percutaneous MWA combined with simultaneous TACE at our center. The clinical data were collected and analyzed for survival and prognostic factors.

resultsThe mean follow-up time was 23.6 ± 14.7 months. One patient had grade 3 complications, and the median overall survival was 12.0 months (95% confidence interval 9.7-14.3). Multivariate analysis showed that Child-Pugh class, serum alpha-fetoprotein level, and Eastern Cooperative Oncology Group performance status were independent factors of survival.

conclusionOur results suggest that percutaneous MWA combined with simultaneous TACE is a safe and effective treatment for HCC with MVI/EHM.

Indexed as

Combination therapyHepatocellular carcinomaMicrowave ablationSurvival

Identifiers

PMID34805873
PMCPMC8562208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.